Literature DB >> 11016535

Age-related changes of apoptotic cell death in human lymphocytes.

K Schindowski1, S Leutner, W E Müller, A Eckert.   

Abstract

Apoptosis seems to be involved in immunosenescence associated with aging. Moreover, in lymphocytes (PBL) of patients with Alzheimer's disease, an increased susceptibility to the apoptotic pathway has been described possibly due to impaired protection of oxidative stress. Accordingly, it seemed to be of particular interest to investigate the contribution of normal aging to the susceptibility from human lymphocytes to programmed cell death. We could show that PBL from elderly individuals (>60 years) accumulate apoptosing cells to a significant higher extent in spontaneous and activation-induced cell death compared to younger controls (<35 years). Treatment with the oxidative stressor 2-deoxy-D-ribose or with agonistic-CD95-antibody pronounced this effect even more implicating a higher sensitivity to reactive oxygen species and a higher functional CD95 expression, respectively. In addition, expression of the activation markers HLA-DR and CD95 was significantly increased in CD3+-cells of aged subjects, while expression of CD25 did not seem to be affected by age. Expression of Bcl-2 was increased in aging and correlated with the number of apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016535     DOI: 10.1016/s0197-4580(00)00171-8

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  12 in total

1.  Bcl-2 activates a programme of premature senescence in human carcinoma cells.

Authors:  Elvira Crescenzi; Giuseppe Palumbo; Hugh J M Brady
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 2.  The immune system in the elderly: activation-induced and damage-induced apoptosis.

Authors:  Lia Ginaldi; Massimo De Martinis; Daniela Monti; Claudio Franceschi
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  Increased T-cell reactivity and elevated levels of CD8+ memory T-cells in Alzheimer's disease-patients and T-cell hyporeactivity in an Alzheimer's disease-mouse model: implications for immunotherapy.

Authors:  Katharina Schindowski; Anne Eckert; Jürgen Peters; Corinna Gorriz; Uta Schramm; Thomas Weinandi; Konrad Maurer; Lutz Frölich; Walter E Müller
Journal:  Neuromolecular Med       Date:  2007-10-26       Impact factor: 3.843

Review 4.  Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Authors:  Kristina Leuner; Kathrin Schulz; Tanja Schütt; Johannes Pantel; David Prvulovic; Virginie Rhein; Egemen Savaskan; Christian Czech; Anne Eckert; Walter E Müller
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

5.  Iron dysregulation combined with aging prevents sepsis-induced apoptosis.

Authors:  Pardis Javadi; Timothy G Buchman; Paul E Stromberg; Isaiah R Turnbull; Dinesh Vyas; Richard S Hotchkiss; Irene E Karl; Craig M Coopersmith
Journal:  J Surg Res       Date:  2005-09       Impact factor: 2.192

6.  Antioxidant micronutrients improve intrinsic and UV-induced apoptosis of human lymphocytes particularly in elderly people.

Authors:  A G Ma; S Ge; M Zhang; X X Shi; E G Schouten; F J Kok; Y Y Sun; X X Han
Journal:  J Nutr Health Aging       Date:  2011-12       Impact factor: 4.075

Review 7.  Can peripheral leukocytes be used as Alzheimer's disease biomarkers?

Authors:  Kavon Rezai-Zadeh; David Gate; Christine A Szekely; Terrence Town
Journal:  Expert Rev Neurother       Date:  2009-11       Impact factor: 4.618

Review 8.  Gene polymorphisms, apoptotic capacity and cancer risk.

Authors:  Evgeny N Imyanitov
Journal:  Hum Genet       Date:  2009-02-12       Impact factor: 4.132

9.  Aging-related changes in the expression of apoptosis-associated molecules in neurosecretory cells of the mouse hypothalamus.

Authors:  E D Bazhanova; V N Molodtsov; K I Pavlov
Journal:  Neurosci Behav Physiol       Date:  2008-01

10.  Impact of aging: sporadic, and genetic risk factors on vulnerability to apoptosis in Alzheimer's disease.

Authors:  Katharina Schindowski; Tilmann Kratzsch; Jürgen Peters; Barbara Steiner; Silke Leutner; Natalie Touchet; Konrad Maurer; Christian Czech; Laurent Pradier; Lutz Frölich; Walter E Müller; Anne Eckert
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.